Vandria’s VNA-318 enters clinical trials for treating age-related diseases
Vandria - 18-Dec-2024Early tests have shown VNA-318 could improve brain function and reduce brain cell damage
Join the club for FREE to access the whole archive and other member benefits.
Known as “the powerhouse of the cell”, mitochondria generate most of the cell’s supply of adenosine triphosphate (ATP) which transports chemical energy within cells for metabolism. They are membrane-bound organelle found in most eukaryotic cells.
Early tests have shown VNA-318 could improve brain function and reduce brain cell damage
Long-term follow-up data and post-hoc analyses fuel optimism for treating mitochondrial diseases
Phase 2 trial on sonlicromanol to test its ability in improving patient's symptoms & quality of life
Chronic inflammation and fibrosis further damage the heart health
Click on resource name for more details.
Cellvie develops cell-derived medicines, leveraging the therapeutic potential of mitochondria, the powerhouses of the cell
Biopharmaceutical company focused on the discovery and commercialization of novel therapies..
Reactive oxygen species (ROS) have a positive role in some processes, complicating research, but unlikely that antioxidants slow ageing
Review paper from University of Helsinki looks at the role of mitophagy in ageing